[Posttraumatic infection with a lactose splitting variant of Pasteurella multocida].
D000368:Aged; D000372:Agglutination Tests; D000667:Ampicillin / Q000494:pharmacology; D002481:Cellulitis / Q000209:etiology* / Q000382:microbiology; D002511:Cephalosporins / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D048909:Diabetes Complications; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D005779:Immunodiffusion; D008297:Male; D009355:Neomycin / Q000494:pharmacology; D010325:Pasteurella / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D010326:Pasteurella Infections / Q000175:diagnosis / Q000382:microbiology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D012811:Sigmoid Neoplasms / Q000150:complications; D013449:Sulfonamides / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014946:Wound Infection / Q000382:microbiology*; D014947:Wounds and Injuries / Q000382:microbiology*
D002511:Cephalosporins; D013449:Sulfonamides; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D009355:Neomycin; D010400:Penicillin G
Posttraumatische Infektion durch eine laktose-spaltende Variante von Pasteurella multocida.